CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 3
- ScaleMarket cap is $6.26B, above the global median of $1.15B
- FinancialsAltman Z-Score 0.76: distress zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
42.08BCNY6.26B · vs all stocks (USD)
Trailing P/E
55.50xRevenue (TTM)
81.33BCNY12.09B · vs all stocks (USD)
Profit Margin
0.83%52-Week Change
7.25%vs all stocks
Market Capitalization
42.08BCNY6.26B · vs all stocks (USD)
Enterprise Value
68.91BCNY10.25B · vs all stocks (USD)
Trailing P/E
55.50xForward P/E
31.71xPEG Ratio
-6.66xPrice to Sales (TTM)
0.5175xPrice to Book (MRQ)
4.24xEnterprise to Revenue
0.8470xEnterprise to EBITDA
13.58xGross Margin
8.59%Profit Margin
0.83%Operating Margin
3.76%Return on Assets (TTM)
1.66%Return on Equity (TTM)
7.01%Revenue (TTM)
81.33BCNY12.09B · vs all stocks (USD)
Revenue per Share (TTM)
4.33CNYUpdated Aug 20, 2026Quarterly Revenue Growth
1.00%Gross Profit (TTM)
6.62BCNY984.35M · vs all stocks (USD)
EBITDA (TTM)
1.68BCNY249.78M · vs all stocks (USD)
Net Income (TTM)
676.12MCNY100.55M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
11.30%Operating Cash Flow (TTM)
7.43BCNY1.11B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
741.11MCNY110.21M · vs all stocks (USD)
5-Year Average Dividend Yield
0.75%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
11.30MCNYFY2025 · Dec 31, 2025Revenue
80.71BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
74.16BCNYFY2025 · Dec 31, 2025Gross Profit
6.55BCNYFY2025 · Dec 31, 2025Operating Income
1.86BCNY276.54M · vs all stocks (USD)
Pre-tax Income
1.20BCNYFY2025 · Dec 31, 2025Income Tax Expense
539.24MCNYFY2025 · Dec 31, 2025Net Income
660.05MCNYFY2025 · Dec 31, 2025EBIT
1.93BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
5.44BCNYFY2025 · Dec 31, 2025Research & Development
2.28BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
573.20MCNYFY2025 · Dec 31, 2025Other Operating Expenses
379.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
73.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
730.90MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
660.05MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.21MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
5.64BCNYFY2025 · Dec 31, 2025Free Cash Flow
3.09BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.66BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
660.05MCNYFY2025 · Dec 31, 2025Other Non-cash Items
4.05BCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.02BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-88.23MCNYFY2025 · Dec 31, 2025Capital Expenditures
-2.56BCNYFY2025 · Dec 31, 2025Sale of Investments
22.12MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.53BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
33.11BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-34.76BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-625.25MCNYFY2025 · Dec 31, 2025Other Financing Charges
-561.48MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.84BCNYFY2025 · Dec 31, 2025Shares Outstanding
18.96BSharesUpdated Aug 20, 2026Float Shares
5.39BSharesUpdated Aug 20, 2026% Held by Insiders
80.30%vs all stocks
% Held by Institutions
1.10%vs all stocks
Total Cash (MRQ)
5.07BCNY753.23M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2650CNYUpdated Aug 20, 2026Total Debt (MRQ)
31.48BCNY4.68B · vs all stocks (USD)
Total Debt to Equity (MRQ)
3.14xCurrent Ratio (MRQ)
0.7170xBook Value per Share (MRQ)
0.5230CNYUpdated Aug 20, 2026Total Assets
77.25BCNY11.49B · vs all stocks (USD)
Total Current Assets
44.34BCNYFY2025 · Dec 31, 2025Total Liabilities
67.99BCNYFY2025 · Dec 31, 2025Total Non-current Assets
32.91BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.81BCNYFY2025 · Dec 31, 2025Total Current Liabilities
66.18BCNYFY2025 · Dec 31, 2025Cash
3.80BCNYFY2025 · Dec 31, 2025Cash Equivalents
1.21BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
5.01BCNYFY2025 · Dec 31, 2025Accounts Receivable
11.17BCNYFY2025 · Dec 31, 2025Inventory
1.13BCNYFY2025 · Dec 31, 2025Accounts Payable
24.79BCNYFY2025 · Dec 31, 2025Short-term Debt
28.72BCNYFY2025 · Dec 31, 2025Long-term Debt
1.45BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
88.83MCNYFY2025 · Dec 31, 2025Common Stock (Book)
18.96BCNYFY2025 · Dec 31, 2025Retained Earnings
-21.93BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.27BCNY1.38B · vs all stocks (USD)
52-Week Low
1.98CNYUpdated Aug 20, 202652-Week High
4.42CNYUpdated Aug 20, 202652-Week Change
7.25%vs all stocks
50-Day MA
2.16CNYUpdated Aug 20, 2026200-Day MA
2.54CNYUpdated Aug 20, 2026Avg 10-Day Volume
139.23MSharesUpdated Aug 20, 2026Avg 30-Day Volume
174.93MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.0400CNYUpdated Aug 20, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
High OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-Deceleration
Cash covers reported profit and gross profit is up, with margins high and growth slowing.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.76: distress zoneCritical
Altman Z-Score: 0.76
High earnings qualityNotable
Earnings Quality Score: 1.24
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Market cap is $6.26B, above the global median of $1.15BNotable
Market cap (USD): 6,258,407,074.494Global Median: 1,146,734,693.424
Revenue is $12.09B, above the global median of $520.53MNotable
Revenue (USD): 12,093,942,881.649Global Median: 520,528,949.311
Levered free cash flow is $110.21M, above the global median of $16.24MNotable
Levered free cash flow (USD): 110,210,184.956Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Longsheng Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Coromandel International Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenzhen Sunlord Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Apl Apollo Tubes Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Brookfield Renewable Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Dazhong Mining Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
AU Optronics Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CNGR Advanced Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Rainbow Robotics Co.,Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Hoshine Silicon Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Xiangxue Pharmaceutical Co., Ltd.
3 interpretationsElevated Leverage on Three DenominatorsPartial Recovery After Sharp DeclineWithin or Near the Altman Distress Zone
Jolywood Suzhou Sunwatt Co., Ltd.
3 interpretationsElevated Leverage on Three DenominatorsPartial Recovery After Sharp DeclineWithin or Near the Altman Distress Zone
Inzone Group Co., Ltd.
3 interpretationsElevated Leverage on Three DenominatorsClose Below 40W SMA With ProfitabilityWithin or Near the Altman Distress Zone